Volume 76, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


Efficacy of the new antipoxvirus compound ST-246 was evaluated as treatment of monkeypox (MPX) virus infection in a ground squirrel model of the disease. Ground squirrels were given a lethal dose of MPX virus and were then treated orally at various times post-inoculation (pi) with 100 mg/kg/day of ST-246. Morbidity and mortality, clinical laboratory results, viral load, and pathology of placebo and treatment groups were compared. All animals that started treatment with ST-246 on days 0, 1, 2, and 3 pi survived lethal challenge with MPX virus; 67% of animals treated on day 4 pi also survived. In contrast, 100% of the placebo group died. Most of the ST-246-treated animals showed no evidence of clinical disease or alteration of baseline clinical laboratory values and had minimal histopathologic changes. These results suggest that ST-246 is a promising candidate for early treatment of severe orthopoxvirus infection.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID, 1988. Smallpox and its Eradication. Geneva: World Health Organization.
  2. Henderson DA, 1998. Bioterrorism as a public health threat. Emerg Infect Dis 4 : 488–492.
    [Google Scholar]
  3. Alibek K, Handelman S, 1999. Biohazard. London: Random House.
  4. Fenner F, 2002. Poxviruses. Richman DD, Whitley RJ, Hayden FG, eds. Clinical Virology. Second edition. Washington, DC: American Society for Microbiology Press, 359–374.
  5. Tesh RB, Watts DM, Sbrana E, Siirin M, Popov VL, Xiao SY, 2004. Experimental infection of ground squirrels (Spermophilus tridecemlineatus) with monkeypox virus. Emerg Infect Dis 10 : 1563–1567.
    [Google Scholar]
  6. Sbrana E, Xiao SY, Newman PC, Tesh RB, 2007. Comparative pathology of North American and central African strains of monkeypox virus in a ground squirrel model of the disease. Am J Trop Med Hyg 76 : 155–164.
    [Google Scholar]
  7. Yang G, Pevear DC, Davies MH, Collett MS, Bailey T, Rippen S, Barone L, Burns C, Rhodes G, Tohan S, Huggins JW, Baker RO, Buller RLM, Touchette E, Waller K, Schriewer J, Neyts J, CeClercq E, Jones K, Hruby D, Jordan R, 2005. An orally bioavailable antipoxvirus compound (ST-246) inhibits extra-cellular virus formation and protects mice from lethal orthopoxvirus challenge. J Virol 79 : 13139–13149.
    [Google Scholar]
  8. Likos AM, Sammons SA, Olson VA, Frace AM, Li Y, Olsen-Rasmussen M, Davidson W, Galloway R, Khristova ML, Reynolds MG, Zhao H, Carroll DS, Curns A, Formenty P, Esposito JJ, Regnery RL, Damon IK, 2000. A tale of two clades: monkeypox viruses. J Gen Virol 86 : 2661–2672.
    [Google Scholar]
  9. Xiao SY, Sbrana E, Watts DM, Siirin M, Travassos da Rosa APA, Tesh RB, 2005. Experimental infection of prairie dogs (Cynomys ludovicianus) with monkeypox virus. Emerg Infect Dis 11 : 539–545.
    [Google Scholar]

Data & Media loading...

  • Received : 13 Jul 2006
  • Accepted : 31 Dec 2006
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error